Asterias Biotherapeutics, Inc. - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - March 29, 2016

Attached files

file filename
EX-31 - EXHIBIT 31 - Asterias Biotherapeutics, Inc.ex31.htm
EX-23.1 - EXHIBIT 23.1 - Asterias Biotherapeutics, Inc.ex23_1.htm
EX-10.31 - EXHIBIT 10.31 - Asterias Biotherapeutics, Inc.ex10_31.htm
EX-10.33 - EXHIBIT 10.33 - Asterias Biotherapeutics, Inc.ex10_33.htm
EX-10.35 - EXHIBIT 10.35 - Asterias Biotherapeutics, Inc.ex10_35.htm
EX-10.34 - EXHIBIT 10.34 - Asterias Biotherapeutics, Inc.ex10_34.htm
EX-10.32 - EXHIBIT 10.32 - Asterias Biotherapeutics, Inc.ex10_32.htm
10-K - ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2015 - Asterias Biotherapeutics, Inc.form10k.htm
EX-32 - EXHIBIT 32 - Asterias Biotherapeutics, Inc.ex32.htm
EXHIBIT 23.2

CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Registration Statements and related Prospectus of Asterias Biotherapeutics, Inc. (the “Company”) on Form S-3 (Registration No. 333-200745 and 333-204441) and on Form S-8 (Registration No. 333-202674 and 333-206237) of our report dated March 17, 2014, with respect to the financial statements of the Company for the year ended December 31, 2013, included in its Annual Report (Form 10-K) for the year ended December 31, 2015, filed with the U.S. Securities and Exchange Commission.
 
/s/ Rothstein Kass

New York, New York
March 29, 2016
 
 

Asterias Biotherapeutics, Inc. Reports